Sustained tocilizumab-induced hypofibrinogenemia and thrombocytopenia. Comment on: "Tocilizumab-induced hypofibrinogenemia: A report of 7 cases" by Martis et al., Joint Bone Spine 2016, doi: 10.1016/j.jbspin.2016.04.008

Affiliations

¹ School of Allergy and Clinical Immunology, Experimental and Clinical Medicine Department, University of Florence, 50134 Florence, Italy. Electronic address: gianfranco.vitiello@unifi.it.
² School of Allergy and Clinical Immunology, Experimental and Clinical Medicine Department, University of Florence, 50134 Florence, Italy.
³ Cardiology Unit, Careggi University Hospital (AOUC), 50134 Florence, Italy.
⁴ Rheumatology Section, Immunoallergology Unit, Careggi University Hospital (AOUC), 50134 Florence, Italy.

Comment

Gianfranco Vitiello et al. Joint Bone Spine. 2017 Oct.

. 2017 Oct;84(5):649-650.

doi: 10.1016/j.jbspin.2017.02.012. Epub 2017 Mar 28.

¹ School of Allergy and Clinical Immunology, Experimental and Clinical Medicine Department, University of Florence, 50134 Florence, Italy. Electronic address: gianfranco.vitiello@unifi.it.
² School of Allergy and Clinical Immunology, Experimental and Clinical Medicine Department, University of Florence, 50134 Florence, Italy.
³ Cardiology Unit, Careggi University Hospital (AOUC), 50134 Florence, Italy.
⁴ Rheumatology Section, Immunoallergology Unit, Careggi University Hospital (AOUC), 50134 Florence, Italy.

No abstract available

Keywords: Biologics; Hypofibrinogenemia; Interleukin-6; Large-vessel vasculitis; Tocilizumab.

Comment on

Tocilizumab-induced hypofibrinogenemia: A report of 7 cases.
Martis N, Chirio D, Queyrel-Moranne V, Zenut MC, Rocher F, Fuzibet JG. Martis N, et al. Joint Bone Spine. 2017 May;84(3):369-370. doi: 10.1016/j.jbspin.2016.04.008. Epub 2016 Jun 17. Joint Bone Spine. 2017. PMID: 27324602 No abstract available.